Arrowhead Pharmaceuticals
ARWR
$21.87
Share price
-6.10%
Change (1 day)
-34.87%
Change (1 year)
Categories
Arrowhead Pharmaceuticals (ARWR) Fails to deliver data
Key failure to deliver metrics for Arrowhead Pharmaceuticals :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $1.53 M
- Last 3 months FTD volume: $4.24 M
- Last year FTD volume: $8.64 M
Failures to deliver for Arrowhead Pharmaceuticals (ARWR) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Arrowhead Pharmaceuticals (ARWR) - since 2016
Volume in USD (price x number of shares), data since 2016Arrowhead Pharmaceuticals (ARWR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $4.23 M | -32.67% |
| 2023 | $6.28 M | 39.55% |
| 2022 | $4.5 M | -73.07% |
| 2021 | $16.73 M | -49.26% |
| 2020 | $32.99 M | -52.98% |
| 2019 | $70.16 M | 188.2% |
| 2018 | $24.34 M | 233.16% |
| 2017 | $7.3 M | -4.53% |
| 2016 | $7.65 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Moderna
MRNA | $43.85 M | $0.12 B | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.58 M | $3.53 M | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.22 M | $43.68 M | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | $3.05 M | $3.05 M | 🇺🇸 USA |